Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation

American Journal of Cardiology

Volumn 119, Issue 7, 2017, Pages 1088-1093

  Mangieri, Antonio ^a   Jabbour, Richard J ^a   Montalto, Claudio ^a   Pagnesi, Matteo ^a   Regazzoli, Damiano ^a   Ancona, Marco B ^a   Giannini, Francesco ^a,b   Tanaka, Akihito ^a   Bertoldi, Letizia ^a   Monaco, Fabrizio ^a   Agricola, Eustachio ^a   Giglio, Manuela ^a   Mattioli, Roberto ^c   Ferri, Luca ^a   Montorfano, Matteo ^a   Chieffo, Alaide ^a   Alfieri, Ottavio ^a   Colombo, Antonio ^a,b   Latib, Azeem ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c Italian Diagnostic Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN; ANTITHROMBOCYTIC AGENT;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; AGED; ANTICOAGULANT THERAPY; AORTA VALVE STENOSIS; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL OUTCOME; CORONARY ARTERY OBSTRUCTION; DATA BASE; DRUG CONTRAINDICATION; DUAL ANTIPLATELET THERAPY; EUROSCORE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL MORTALITY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; ITALY; LIFE THREATENING BLEEDING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NEW YORK HEART ASSOCIATION CLASS; NEW-ONSET ATRIAL FIBRILLATION; PACEMAKER IMPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; SOCIETY OF THORACIC SURGEONS SCORE; THROMBOCYTOPENIA; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; VERY ELDERLY; COMBINATION DRUG THERAPY; CONTRAINDICATIONS; DOSE RESPONSE; ECHOCARDIOGRAPHY; HEMORRHAGE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME;

AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; ITALY; MALE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85013421179     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.11.065     Document Type: Article

References (14)

1. 1 Mangieri, A., Regazzoli, D., Ruparelia, N., Colombo, A., Latib, A., Recent advances in transcatheter aortic valve replacement for high-risk patients. Expert Rev Cardiovasc Ther 13 (2015), 1237–1249.
2. 2 Généreux, P., Cohen, D.J., Williams, M.R., Mack, M., Kodali, S.K., Svensson, L.G., Kirtane, A.J., Xu, K., McAndrew, T.C., Makkar, R., Smith, C.R., Leon, M.B., Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63 (2014), 1100–1109.
3. 3 Makkar, R.R., Fontana, G.P., Jilaihawi, H., Kapadia, S., Pichard, A.D., Douglas, P.S., Thourani, V.H., Babaliaros, V.C., Webb, J.G., Herrmann, H.C., Bavaria, J.E., Kodali, S., Brown, D.L., Bowers, B., Dewey, T.M., Svensson, L.G., Tuzcu, M., Moses, J.W., Williams, M.R., Siegel, R.J., Akin, J.J., Anderson, W.N., Pocock, S., Smith, C.R., Leon, M.B., PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366 (2012), 1696–1704.
4. 4 Figini, F., Latib, A., Maisano, F., Montorfano, M., Chieffo, A., Carlino, M., Cioni, M., Basavarajaiah, S., Ferrarello, S., Giannini, F., Alfieri, O., Colombo, A., Managing patients with an indication for anticoagulant therapy after transcatheter aortic valve implantation. Am J Cardiol 111 (2013), 237–242.
5. 5 Kappetein, A.P., Head, S.J., Généreux, P., Piazza, N., van Mieghem, N.M., Blackstone, E.H., Brott, T.G., Cohen, D.J., Cutlip, D.E., van Es, G.A., Hahn, R.T., Kirtane, A.J., Krucoff, M.W., Kodali, S., Mack, M.J., Mehran, R., Rodés-Cabau, J., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W., Leon, M.B., Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 145 (2013), 6–23.
6. 6 Latib, A., Naganuma, T., Abdel-Wahab, M., Danenberg, H., Cota, L., Barbanti, M., Baumgartner, H., Finkelstein, A., Legrand, V., de Lezo, J.S., Kefer, J., Messika-Zeitoun, D., Richardt, G., Stabile, E., Kaleschke, G., Vahanian, A., Laborde, J.C., Leon, M.B., Webb, J.G., Panoulas, V.F., Maisano, F., Alfieri, O., Colombo, A., Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv, 8, 2015.
7. 7 Del Trigo, M., Muñoz-Garcia, A.J., Wijeysundera, H.C., Nombela-Franco, L., Cheema, A.N., Gutierrez, E., Serra, V., Kefer, J., Amat-Santos, I.J., Benitez, L.M., Mewa, J., Jiménez-Quevedo, P., Alnasser, S., Garcia Del Blanco, B., Dager, A., Abdul-Jawad Altisent, O., Puri, R., Campelo-Parada, F., Dahou, A., Paradis, J.M., Dumont, E., Pibarot, P., Rodés-Cabau, J., Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol 67 (2016), 644–655.
8. 8 Lancellotti, P., Moura, L., Pierard, L.A., Agricola, E., Popescu, B.A., Tribouilloy, C., Hagendorff, A., Monin, J.L., Badano, L., Zamorano, J.L., European Association of Echocardiography. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 11 (2010), 307–332.
9. 9 Borz, B., Durand, E., Godin, M., Tron, C., Canville, A., Litzler, P.Y., Bessou, J.P., Cribier, A., Eltchaninoff, H., Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 99 (2013), 860–865.
10. 10 Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M.J., Barón-Esquivias, G., Baumgartner, H., Borger, M.A., Carrel, T.P., De Bonis, M., Evangelista, A., Falk, V., Lung, B., Lancellotti, P., Pierard, L., Price, S., Schäfers, H.J., Schuler, G., Stepinska, J., Swedberg, K., Takkenberg, J., Von Oppell, U.O., Windecker, S., Zamorano, J.L., Zembala, M., ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 42 (2012), S1–S44.
11. 11 Hassell, M.E.C.J., Hildick-Smith, D., Durand, E., Kikkert, W.J., Wiegerinck, E.M., Stabile, E., Ussia, G.P., Sharma, S., Baan, J. Jr., Eltchaninoff, H., Rubino, P., Barbanti, M., Tamburino, C., Poliacikova, P., Blanchard, D., Piek, J.J., Delewi, R., Antiplatelet therapy following transcatheter aortic valve implantation. Heart 101 (2015), 1118–1125.
12. 12 Nombela-Franco, L., del Trigo, M., Morrison-Polo, G., Veiga, G., Jimenez-Quevedo, P., Abdul-Jawad Altisent, O., Campelo-Parada, F., Biagioni, C., Puri, R., DeLarochellière, R., Dumont, E., Doyle, D., Paradis, J.M., Quirós, A., Almeria, C., Gonzalo, N., Nuñez-Gil, I., Salinas, P., Mohammadi, S., Escaned, J., Fernández-Ortiz, A., Macaya, C., Rodés-Cabau, J., Incidence, causes, and predictors of early (≤30 Days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. JACC Cardiovasc Interv 8 (2015), 1748–1757.
13. 13 Stabile, E., Pucciarelli, A., Cota, L., Sorropago, G., Tesorio, T., Salemme, L., Popusoi, G., Ambrosini, V., Cioppa, A., Agrusta, M., Catapano, D., Moscariello, C., Trimarco, B., Esposito, G., Rubino, P., SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol 174 (2014), 624–627.
14. 14 Ussia, G.P., Scarabelli, M., Mulè, M., Barbanti, M., Sarkar, K., Cammalleri, V., Immè, S., Aruta, P., Pistritto, A.M., Gulino, S., Deste, W., Capodanno, D., Tamburino, C., Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 108 (2011), 1772–1776.